“The Most Renowned Life Science & Medical Solution Providers 2022”
This month’s issue, ‘The Most Renowned Life Science & Medical Solution Providers 2022‘ highlights the tales of a few significant entrepreneurs who are inspiring, influencing, and invigorating others with their zeal to strive for success.
Business Profile
Saama Technologies : AI-Driven Solutions that Empower BioPharma to Accelerated Clinical Trials
Pharmaceutical executives are exploring methods to use artificial intelligence (AI) and machine learning in the pharmaceutical and biotech industries. According to reports, a rising number of organisations are achieving current use cases, which is pushing the digital future of technology in business. Top pharmaceutical businesses are partnering with AI suppliers and using AI technology in their R&D processes and overall drug discovery.
According to surveys, approximately 62% of healthcare organisations are thinking about investing in AI in the near future, and 72% of businesses believe AI will be critical to how they do business in the future.
Techsol: Developing Innovative Software Solutions and Technology Expertise for Pharma
Techsol Corporation was founded in 2010 under the leadership of Satya S S Sagi, CEO with his vision for offering value-based technology services and developing innovative software solutions for pharma. With over 20 years of life sciences industry experience, the humble beginnings of Techsol was started by him on a small penthouse overseeing Hi-Tec city in Hyderabad, India.
Today with our headquarters in Princeton, NJ, we are recognized as a valuable tech partner for several global clients with an expanded team of 140+ subject matter experts.
International Health Management Associates : Redefining the Drug Discovery Process with Unique Solutions
It’s a charismatic century where the world is changing its way by adopting and adapting to the technological disruptions. Numerous scientific developments and innovations take place throughout industries including pharmaceutical and healthcare industries every single day improving the human health and forwarding life-expectancy one step further.
However, the cost of drug-development or discovery process continues to rise and the chances of success continues to plummet. According to McKinsey, every years, the top 20 pharmaceutical companies spend approximately $60 billion on the research and development of drug discovery.
Aragen Life Sciences: Post pandemic future for CROs/CDMOs in India by Mr. Manni Kantipudi
The outsourced pharma services sector, of which CROs/ CDMOs (Contract Development and Manufacturing organizations) is a part of, is growing rapidly; and have become one of the key components of the pharma and life sciences industry.
Their growing importance is a result of rationalization of the cost base due to pricing pressure, patent expiries and increasing costs. Hence, R&D outsourcing has become a ‘must have’ than ‘good-to have’ strategy over the past few years.
